| 04/16/2026 8:11 AM | Tenaya Therapeutics (1858848) Filer | Form DEFA14A | |
| 04/16/2026 8:14 AM | Tenaya Therapeutics (1858848) Filer | Form ARS | |
| 04/16/2026 8:00 AM | Tenaya Therapeutics (1858848) Filer | Form DEF 14A | |
| 03/11/2026 3:14 PM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/05/2026 7:35 AM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 3:13 PM | COLUMN GROUP III GP, LP (1790965) Reporting COLUMN GROUP III, LP (1668159) Reporting COLUMN GROUP III-A, LP (1668085) Reporting Column Group Opportunity III GP, LP (1932874) Reporting Column Group Opportunity III, LP (1931825) Reporting Kutzkey Tim (1614186) Reporting Svennilson Peter (1606074) Reporting TCG Opportunity III GP, LLC (1932445) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:35 PM | COLUMN GROUP III-A, LP (1668085) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/20/2026 4:37 PM | COLUMN GROUP III, LP (1668159) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 6:09 PM | Tenaya Therapeutics (1858848) Subject Tingley Whittemore (1868494) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 6:12 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/17/2026 6:13 PM | Tenaya Therapeutics (1858848) Issuer Tingley Whittemore (1868494) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TNYA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/17/2026 6:14 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 6:15 PM | Higa Tomohiro (2054280) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 5:52 PM | COLUMN GROUP III, LP (1668159) Filed by Tenaya Therapeutics (1858848) Subject | Form SCHEDULE 13D/A | |
| 02/12/2026 4:19 PM | COLUMN GROUP III GP, LP (1790965) Reporting COLUMN GROUP III, LP (1668159) Reporting COLUMN GROUP III-A, LP (1668085) Reporting Column Group Opportunity III GP, LP (1932874) Reporting Column Group Opportunity III, LP (1931825) Reporting Kutzkey Tim (1614186) Reporting Svennilson Peter (1606074) Reporting TCG Opportunity III GP, LLC (1932445) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 4:52 PM | COLUMN GROUP III, LP (1668159) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/11/2026 4:57 PM | COLUMN GROUP III-A, LP (1668085) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 4:25 PM | COLUMN GROUP III-A, LP (1668085) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/05/2026 5:02 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:02 PM | Tenaya Therapeutics (1858848) Issuer Tingley Whittemore (1868494) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:03 PM | Higa Tomohiro (2054280) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 4:10 PM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 3:16 PM | COLUMN GROUP III, LP (1668159) Filed by Tenaya Therapeutics (1858848) Subject | Form SCHEDULE 13D/A | |
| 12/12/2025 3:30 PM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 3:18 PM | Tenaya Therapeutics (1858848) Filer | Form 424B5 | |
| 12/11/2025 3:42 PM | Tenaya Therapeutics (1858848) Filer | Form 424B5 | |
| 11/17/2025 7:33 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 7:34 PM | Tenaya Therapeutics (1858848) Issuer Tingley Whittemore (1868494) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 7:34 PM | Higa Tomohiro (2054280) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 6:07 AM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/10/2025 6:12 AM | Tenaya Therapeutics (1858848) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/07/2025 3:24 PM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2025 7:56 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2025 7:57 PM | Tenaya Therapeutics (1858848) Subject Tingley Whittemore (1868494) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2025 7:58 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 7:59 PM | Tenaya Therapeutics (1858848) Issuer Tingley Whittemore (1868494) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 8:00 PM | Higa Tomohiro (2054280) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2025 6:02 PM | BlackRock, Inc. (2012383) Filed by Tenaya Therapeutics (1858848) Subject | Form SCHEDULE 13G/A | |
| 05/30/2025 5:53 PM | Tenaya Therapeutics (1858848) Issuer Walsh Jeffrey T. (1578251) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:54 PM | Stehman-Breen Catherine (1702233) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:48 PM | Parschauer Karah Herdman (1677455) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 05/30/2025 5:50 PM | Lee June (1696493) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:50 PM | Srivastava Deepak (1868501) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:51 PM | Tenaya Therapeutics (1858848) Issuer Williams R Sanders (1375347) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:52 PM | GOEDDEL DAVID V (1182464) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/30/2025 5:52 PM | Burroughs Amy L. (1872564) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/16/2025 6:07 PM | Ali Faraz (1667937) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/16/2025 6:07 PM | Tenaya Therapeutics (1858848) Issuer Tingley Whittemore (1868494) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/16/2025 6:07 PM | Higa Tomohiro (2054280) Reporting Tenaya Therapeutics (1858848) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2025 8:32 AM | Tenaya Therapeutics (1858848) Subject Woodline Partners LP (1784547) Filed by | Form SCHEDULE 13G | |
| 05/14/2025 3:18 PM | COLUMN GROUP III, LP (1668159) Filed by Tenaya Therapeutics (1858848) Subject | Form SCHEDULE 13D/A | |
| 05/07/2025 3:18 PM | Tenaya Therapeutics (1858848) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2025 8:31 AM | Empery Asset Management, LP (1469336) Filed by Tenaya Therapeutics (1858848) Subject | Form SCHEDULE 13G | |